Cyclazodone: Difference between revisions

Line 5:

'''N-Cyclopropylpemoline''' (also known as '''Cyclazodone''') is a centrally acting [[psychoactive class::stimulant]] substance of the [[chemical class::4-oxazolidinone]] chemical class that produces classical [[dopamine|dopaminergic]] stimulation, [[focus enhancement|focus enhancing]], and mild [[entactogen|entactogenic]] effects when [[administered]]. Its effects have been compared to those of [[amphetamine]], but with the addition of a low to moderate affinity for [[serotonin]] release comparable to that of [[methamphetamine]] and [[3-FMA]]. It is structurally related to [[pemoline]] and [[4-methylaminorex]].

Cyclazodone was developed by the American Cyanamid Company in the 1960s. Its non-clinical use has only found recent attention as a ~~potential~~[[research chemical]] study aid. It should be noted that the lack of pharmacological data and extremely limited history of human usage pose considerable concern regarding its long-term use as a substitute for prescription stimulants.

Cyclazodone was developed by the American Cyanamid Company in the 1960s. Its non-clinical use has only found recent attention as a [[research chemical]] study aid. It should be noted that the lack of pharmacological data and extremely limited history of human usage pose considerable concern regarding its long-term use as a substitute for prescription stimulants.

Cyclazodone has no documented history of recreational human usage before it appeared on the online research chemical market in 2017. Based on related compounds, it is speculated that it likely possesses hepatotoxic and other not-yet-known toxic properties. It is strongly advised to use [[responsible drug use|harm reduction practices]] if using this substance.

@@ Line 5: / Line 5: @@
 '''N-Cyclopropylpemoline''' (also known as '''Cyclazodone''') is a centrally acting [[psychoactive class::stimulant]] substance of the [[chemical class::4-oxazolidinone]] chemical class that produces classical [[dopamine|dopaminergic]] stimulation, [[focus enhancement|focus enhancing]], and mild [[entactogen|entactogenic]] effects when [[administered]]. Its effects have been compared to those of [[amphetamine]], but with the addition of a low to moderate affinity for [[serotonin]] release comparable to that of [[methamphetamine]] and [[3-FMA]]. It is structurally related to [[pemoline]] and [[4-methylaminorex]].
-Cyclazodone was developed by the American Cyanamid Company in the 1960s. Its non-clinical use has only found recent attention as a potential[[research chemical]] study aid. It should be noted that the lack of pharmacological data and extremely limited history of human usage pose considerable concern regarding its long-term use as a substitute for prescription stimulants.
+Cyclazodone was developed by the American Cyanamid Company in the 1960s. Its non-clinical use has only found recent attention as a [[research chemical]] study aid. It should be noted that the lack of pharmacological data and extremely limited history of human usage pose considerable concern regarding its long-term use as a substitute for prescription stimulants.
 Cyclazodone has no documented history of recreational human usage before it appeared on the online research chemical market in 2017. Based on related compounds, it is speculated that it likely possesses hepatotoxic and other not-yet-known toxic properties. It is strongly advised to use [[responsible drug use|harm reduction practices]] if using this substance.